Common Names
Geographic Range: Pacific Islands — Vanuatu (likely center of domestication), Fiji, Tonga, Samoa, Hawaii, Papua New Guinea. Cultivated vegetatively (does not produce seeds).
Known Contraindications
1
Compounds
1
Traditions
1
Treatments
2
Conditions
COC1=CC(=O)OC(C=Cc2ccccc2)C1CYP Interaction Profile
| Enzyme | Interaction |
|---|---|
| CYP1A2 | moderate inhibitor |
| CYP2B6 | weak inhibitor |
| CYP2C9 | potent inhibitor (kavain primary metabolism) |
| CYP2D6 | moderate inhibitor |
| CYP3A4 | moderate inhibitor |
| CYP2C19 | moderate inhibitor |
| clinical_note | BROAD CYP inhibition profile — kavain and dihydrokavain inhibit multiple CYP isoforms. Significant drug interaction potential. Potentiates CNS depressants. AVOID with alcohol, benzodiazepines, hepatotoxic drugs. Traditional aqueous extraction produces lower kavalactone concentrations than modern organic solvent extracts. |